ea0081rc8.6 | Rapid Communications 8: Calcium and Bone | ECE2022
Palermo Andrea
, Vokes Tamara J
, Khan Aliya
, Rubin Mishaela
, Schwarz Peter
, Clarke Bart L
, Eriksen Erik
, Marcocci Claudio
, Pagotto Uberto
, Tsourdi Elena
, Sikjaer Tanja
, Brod Meryl
, Mcleod Lori
, Markova Denka
, Noori Wahidullah
, Eng Walter Frank
, Shu Aimee
, Smith Alden
Background: Patients with hypoparathyroidism experience significant physical and cognitive symptoms and reduced health-related quality of life (HRQoL). Conventional therapy for hypoparathyroidism does not fully alleviate diminished HRQoL. The Hypoparathyroidism Patient Experience Scales (HPES) were developed to assess disease-specific physical and cognitive symptoms as well as the impact of hypoparathyroidsm on HRQol. TransCon PTH, an investigational long-acting prodrug of par...